Clinical Research Doctors Pharmacy Regulation 
ACRP blog
NOVEMBER 8, 2023
As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.
ACRP blog
NOVEMBER 8, 2023
As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
DECEMBER 18, 2023
Digital biomarkers promise to transform preventive medicine and clinical trials, but also raise issues of security, regulation and potential disparities in access. Deepika Khedekar, Clinical Trial Lead at IQVIA, provides an overview of the pros and cons, and suggests a possible solution.
pharmaphorum
DECEMBER 1, 2022
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.
ACRP blog
JANUARY 31, 2023
As Christine Senn, PhD, CCRC, CPI, ACRP-CP, FACRP, Chief Integration Officer with Centricity Research, settles into her volunteer duties as the 2023 Chair of the Association Board of Trustees (ABoT) for ACRP, she took time to answer some questions about her outlook on the current state of the Association and the clinical research enterprise.
pharmaphorum
DECEMBER 21, 2021
There has been progress in this area in recent years, with both the European Union (EU), through Regulation (EC) No 1901/2006 , and the US, through the Orphan Drug Act , enacting legislation to encourage the development of therapies for Rare Diseases. Headway being made. The potential to leverage genomic data.
Drug Discovery World
APRIL 14, 2023
Kathryn E Wellen, PhD – Outstanding Achievement in Basic Cancer Research Wellen is an investigator at the Penn Epigenetics Institute and Vice Chair and Professor in the Department of Cancer Biology in the Perelman School of Medicine at the University of Pennsylvania. Delattre’s award lecture will be held on Tuesday April 18 at 5pm ET.
Expert insights. Personalized for you.
59 
Let's personalize your content